Abstract
As highlighted by the ongoing COVID-19 pandemic, vaccination is critical for infectious disease prevention and control. Obesity is associated with increased morbidity and mortality from respiratory virus infections. While obese individuals respond to influenza vaccination, what is considered a seroprotective response may not fully protect the global obese population. In a cohort vaccinated with the 2010-2011 trivalent inactivated influenza vaccine, baseline immune history and vaccination responses were found to significantly differ in obese individuals compared to healthy controls, especially towards the 2009 pandemic strain of A/H1N1 influenza virus. Young, obese individuals displayed responses skewed towards linear peptides versus conformational antigens, suggesting aberrant obese immune response. Overall, these data have vital implications for the next generation of influenza vaccines, and towards the current SARS-CoV-2 vaccination campaign.
One Sentence Summary Obese individuals have altered baseline and post-vaccination influenza antibody repertoires.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The National Institute for Biotechnology in the Negev (TH) Israel Science Foundation Individual Research Grant NO. 882/17 (TH) The Israel-America Foundation and the Ben-Gurion University Center for Multidisciplinary Research in Aging (TH) National Institute of Allergy and Infectious Diseases under HHS contract HHSN27220140006C (EAK and SSC) National Institute of Allergy and Infectious Diseases grant R01 NIH/NIAID/AI078090 (MAB, TLN and SSW) ALSAC (EAK and SSC)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of North Carolina at Chapel Hill IRB committee
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All raw data and code used in the analysis are available upon request
